Emil E Hassan

Director Emil E Hassan sold 5,937 shares of NHC at $200.00 for $1,187,400; stock near 52-week high ($205.90), down -3.7% from peak.

Emil E Hassan (Director) divested 5,937 shares representing 8.3% of his pre-transaction holdings, executing the sale at $200.00 per share when NHC traded near its 52-week high of $205.90. The stock has appreciated 22.8% over the past 90 days and currently sits -3.7% below its 52-week peak, positioning this sale in a period of strong price momentum. Reviewing his same-ticker history at NHC, a prior sell on 2025-11-25 posted a +13.4% return over 90 days post-transaction, indicating the previous sale was poorly timed relative to subsequent upward movement. The company exhibits solid fundamentals with 16.1% annual revenue growth, $35.9M net income on $381.8M quarterly revenue, and a P/E of 25.04.

Director Hassan Emil E sold 7,500 NHC shares at $138.52; retains 65,595 shares post-transaction.

Hassan Emil E (Director) sold 7,500 shares of National Healthcare Corp at $138.52 on 2025-11-25, reducing his holdings by 10.3% to 65,595 shares. The transaction was executed at a price $1.43 above the current market price of $137.18, with the stock having appreciated 14.0% over 30 days and 21.2% over 90 days from the transaction date. The underlying business shows strong fundamentals: annual revenue growth of 14.5%, net income of $39,239,000.00 on revenue of $382,661,000.00, and a P/E of 21.01. While the sale is measurable and reduces a significant director holding, the limited scale of the reduction (10.3%) and the company's solid financial trajectory provide context for the activity.